BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The Basics Behind BPC 157 Injections and Their Effectiveness Your Health Magazine BPC 157 Arginate Therapy for your Healing Simply Wellness BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group GLOW (BPC 157 GHK CU KPV TB500) Injections Team Wellcore